drugset / Trial / NCT00642915

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)

NCT00642915

Phase 4 Completed 100 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To estimate the efficacy of combination therapy with Lantus plus Amaryl in controlling blood glucose in Japanese patients with type 2 diabetes having failed OAD therapy, and document the ability to preserve the endocrine pancreatic function with Lantus plus Amaryl combination therapy

Timeline

Start
2003-06
Primary completion
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Glimepiride Small molecule
Subject insulin glargine Protein / enzyme biologic

Indications